Sanyou Biopharmaceuticals Announces New Strategic Investor; Liferiver Biotech Increases Its Stake, and Gree Group's Yanghe Investment Joins as a Strategic Shareholder
SHANGHAI, Feb. 24, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio"), a biotech company powered by super-trillion-molecule libraries and AI-driven technologies, today announced the completion of a significant equity...
Cboe Global Markets Reports Results for Third Quarter 2025 and Announces Strategic Realignment of Business Portfolio
Third Quarter Highlights* Record Diluted EPS for the Quarter of $2.85, Up 38 percent Record Adjusted Diluted EPS¹ for the Quarter of $2.67, Up 20 percent Record Net Revenue for the Quarter of $605.5 million, Up 14 percent Increases 2025 Organic...